Table 3.
Group | Drug | n | % |
---|---|---|---|
1 | Docetaxel | 10 | 11.1 |
2 | Cyclophosphamide + Docetaxel | 14 | 15.5 |
3 | Cyclophosphamide + Doxorubicin | 15 | 16.7 |
4 | Doxorubicin + Cyclophosphamide+Docetaxel | 16 | 17.8 |
5 | Docetaxel + other antineoplastic agents | 15 | 16.7 |
6 | Other combinations of antineoplastic agents | 20 | 22.2 |